Co-Chair: Kentucky Sen. Julie Denton
Co-Chair: Alabama Sen. Vivian Davis Figures
I. Welcome and Member Introductions
II. Review & Approval of Meeting Summary from 2009 Spring Meeting
III.Reducing Disparities in HIV and STDS: A policy discussion encore from the Atlanta CSG-CDC workshop in July 2009
David Johnson, MPH
Health disparities coordinator, Division of STD Preventions
Centers for Disease Control and Prevention
IV. Approval of Policy Resolutions
Task force members will consider, discuss and vote on policy resolutions submitted for approval. Recommended policy resolutions are forwarded to the CSG Intergovernmental Affairs Committee for consideration, with final approval by the CSG Executive Committee.
V. Review of Suggested State Legislation
Task force members will consider, discuss and vote on health legislation submitted for review. Recommendations are forwarded to the Suggested State Legislation Committee for consideration and final determination about inclusion in CSG’s annual Suggested State Legislation publication.
VI. Task Force Staff Activities Report
VII. Adjourn
David Johnson, MPH
Health disparities coordinator, Division of STD Prevention, CDC
David B. Johnson is the first STD disparities coordinator in the Division of STD Prevention within the Centers for Disease Control and Prevention. He joined the CDC in 1983, and his work focuses on identifying the social determinants that contribute to STDs and HIV disparities among communities of color, including populations that have been marginalized due to sexual orientation.
Johnson, a graduate of the University of North Texas, was trained in behavioral research and ethnography by the University of Texas at Austin. During his tenure with CDC, Johnson has received training and education in sexual behavior and orientation, substance abuse and mental health, qualitative research, program planning and evaluation, and community assessment and outreach.
He has been a guest lecturer at Morehouse College at the School of Public Health and has led courses on HIV, TB, STD and substance abuse. He has published articles in scientific journals and has served as a consultant and technical adviser for a large pharmaceutical company and numerous state and local health departments.